Consumption of a Coffee Rich in Phenolic Compounds May Improve the Body Composition of People with Overweight or Obesity: Preliminary Insights from a Randomized, Controlled and Blind Crossover Study
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(17), P. 2848 - 2848
Published: Aug. 26, 2024
This
study
analyzes
the
effects
on
body
composition
and
variables
related
to
metabolic
syndrome
of
two
coffees
with
different
degree
roasting
phenolic
content.
Sixty
participants
mass
index
between
25
35
kg/m2
a
median
age
51.0
years
(Interquartile
range
46.3–56)
were
recruited.
The
was
controlled,
randomized,
single-blind
crossover
trial
consisting
in
drinking
three
cups/day
roasted
coffee
(RC)
or
lightly
(LRC)
during
12
weeks
2-week
wash-out
stages
before
each
intervention.
LRC
contained
≈400
mg
hydroxycinnamic
acids
≈130
caffeine
per
200
mL/cup
while
RC
≈150
≈70
mL/cup.
Along
study,
six
visits,
blood
pressure,
by
bioimpedance,
anthropometric
measurements,
biochemistry
analyzed.
mean
differences
p
values
calculated
using
linear
mixed
model
(JASP.v.0.18.0.3).
A
total
38
completed
study.
After
consumption
both
coffees,
fat
percentage
(LRC:
−1.4%,
<
0.001;
RC:
−1.0%,
=
0.005)
reduced,
whereas
muscle
slightly
increased
0.8%,
0.7%,
0.002).
decrease
greater
compared
(−0.8%;
0.029).
There
no
significant
changes
weight.
In
conclusion,
superior
at
inducing
composition.
Language: Английский
The Role of Xenobiotic Caffeine on Cardiovascular Health: Promises and Challenges
Journal of Xenobiotics,
Journal Year:
2025,
Volume and Issue:
15(2), P. 51 - 51
Published: March 31, 2025
Cardiovascular
diseases
(CVDs)
represent
a
leading
cause
of
premature
mortality
and
disability
worldwide,
with
their
incidence
expected
to
rise,
potentially
reaching
24
million
deaths
per
year
by
2030.
These
multifactorial
diseases,
including
hypertension,
coronary
artery
disease,
arrhythmia,
heart
failure,
are
often
linked
metabolic
disturbances
such
as
diabetes,
oxidative
stress,
endothelial
dysfunction,
inflammation.
Natural
compounds,
caffeine,
have
been
explored
for
potential
therapeutic
effects
on
CVDs.
Caffeine,
found
in
coffee,
tea,
cocoa,
various
energy
drinks,
is
widely
consumed
psychoactive
compound
noted
analgesic
anti-inflammatory
properties.
Despite
its
long
history
use,
caffeine’s
impact
cardiovascular
health
remains
controversial,
both
beneficial
harmful
reported.
This
review
examines
the
current
literature
caffeine
(CVDs),
an
emphasis
preclinical
clinical
studies,
pharmacokinetic
properties,
molecular
mechanisms
it
modulates.
There
evidence
that
moderate
intake
can
be
some
CVDs,
while
other
dyslipidemia,
collected
so
far
suggests
could
detrimental
since
increases
total
cholesterol
levels.
But
variability
dosage,
patterns,
individual
factors
(such
genetics
diet)
complicates
reliability
results.
Additionally,
challenges
related
dose
standardization
absence
consistent
trial
designs
hinder
full
utilization
CVD
treatment.
Nonetheless,
appears
safe
individuals
without
significant
conditions.
Future
research
should
aim
well-designed
studies
precise
patient
cohorts
standardized
methodologies
better
assess
role
management.
Language: Английский
HABITUAL COFFEE CONSUMPTION AND RISK OF CARDIOVASCULAR AND ALL-CAUSE MORTALITY IN THE PAMELA HYPERTENSIVE POPULATION.
Nutrition Metabolism and Cardiovascular Diseases,
Journal Year:
2024,
Volume and Issue:
unknown, P. 103776 - 103776
Published: Oct. 1, 2024
Language: Английский
Impact of Coffee Intake on Human Aging: Epidemiology and Cellular Mechanisms
Ageing Research Reviews,
Journal Year:
2024,
Volume and Issue:
102, P. 102581 - 102581
Published: Nov. 16, 2024
Language: Английский
Molecular mechanisms of action of DIM and its clinical application
Medical alphabet,
Journal Year:
2024,
Volume and Issue:
19, P. 9 - 15
Published: Oct. 30, 2024
Optimal
nutrition
requires
complete
provision
of
the
human
needs
not
only
for
energy,
macro-
and
micronutrients,
but
also
minor
biologically
active
substances.
Some
most
promising
chemoprotectors
are
glucosinolates
their
derivatives,
such
as
3,3’-diindolylmethane
(DIM).
DIM
has
ability
to
inhibit
development
progression
neoplasia
by
regulating
multiple
intracellular
signaling
pathways.
Currently,
clinical
efficacy
is
being
studied
in
breast
prostate
cancer,
possibility
using
DIM’s
antioxidant
anti-inflammatory
properties
neurodegenerative,
metabolic
immune
diseases
investigated.
Language: Английский